As the understanding of obesity continues to evolve, so too does the science, patient experience, and cross-sector ...

Novartis’ Itvisma (onasemnogene) has been approved by the US FDA to treat spinal muscular atrophy (SMA) in children aged two ...

Go behind the scenes of The participation equation – our call to put people, not just data, at the heart of clinical research ...

Regeneron Pharmaceuticals’ Libtayo (cemiplimab) has received approval from the European Commission for the adjuvant treatment ...

Over the past six decades, anti-thrombotic drug therapies have undergone a revolution, leading to major improvements in ...

Tonix Pharmaceuticals has launched Tonmya (cyclobenzaprine), a newly approved oral treatment for adults with fibromyalgia.

SQD, an innovative recruitment and retention success scoring tool that helps clinical trial sponsors predict, measure, and ...

Discover key insights from ESMO 2025 on how design, emotion, and sustainability are reshaping medical congress experiences.

Can you believe there are still outdated myths about the strategic value Medical Affairs (MA) brings to the table? There’s ...

Inizio today announced the launch of InConcert™, a new AI-powered data solution designed to accelerate smarter, evidence-led ...

Novartis has announced plans to build a new flagship US manufacturing hub in North Carolina. The announcement comes as part ...

The US Food and Drug Administration (FDA) has approved PADCEV (enfortumab), in combination with Keytruda (pembrolizumab) or ...